---
schema_version: "secwatch.filing_event.v1"
accession: "0000849146-23-000205"
form_type: "8-K"
ticker: "LFVN"
cik: "0000849146"
company_name: "Lifevantage Corp"
filed_at: "2023-11-09T23:59:59+00:00"
generated_at: "2026-06-08T08:15:43.181566+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# LifeVantage Q1 FY24 revenue $51.4M (-0.8% YoY); adj. EBITDA +41%, adj. EPS $0.13

## Summary
- Revenue $51.4M, down 0.8% YoY (ex-FX -0.2%). Americas +5.9%, US +6.5%; Asia/Pacific & Europe -16.6% (-14.6% constant currency).
- GAAP EPS $0.05 flat YoY; adjusted EPS $0.13 vs $0.06. Adjusted EBITDA $4.0M, up 41.4% from $2.8M.
- Total active accounts 137k, down 10.5% YoY (Americas -7.5%, APAC/EU -17.0%). Cash from operations $4.8M vs -$1.3M; no debt.
- Dividend $0.035/share declared, payable Dec 15, record Dec 1. FY24 guidance: rev $216M-$226M, adj. EBITDA $16M-$18M, adj. EPS $0.52-$0.62.

## SEC filing metadata
- accession: 0000849146-23-000205
- form_type: 8-K
- ticker: LFVN
- cik: 0000849146
- company_name: Lifevantage Corp
- filed_at: 2023-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/849146/000084914623000205/0000849146-23-000205-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/849146/000084914623000205/lfvn-20231109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000849146-23-000205
- JSON: https://secwatch.observer/filing/0000849146-23-000205.json
- Plain text: https://secwatch.observer/filing/0000849146-23-000205.txt

## Key facts
- Earnings Releases
  Lifevantage Corp reported the first fiscal quarter ended September 30, 2023 results: revenue $51.4 million, net income $0.6 million, EPS $0.05 per diluted share.
  - Period: the first fiscal quarter ended September 30, 2023
  - Revenue: $51.4 million
  - Net income: $0.6 million
  - EPS: $0.05 per diluted share
  - Result: reported results
  source text: to activate optimal health processes, today reported financial results for its first fiscal quarter ended September 30, 2023. First Quarter Fiscal 2024 Summary*: • Revenue of $51.4 million, a decrease of 0.8% from the prior year period. Excluding the negative impact of foreign currency fluctuations, first quarter revenue was down approximately 0.2%; • Revenue in
  evidence_url: https://www.sec.gov/Archives/edgar/data/849146/000084914623000205/0000849146-23-000205-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.